Clinical Trials for Sarcomas
6 Open Trials
| Trial Type | Protocol No. & Open Date | Summary |
|---|---|---|
| Therapeutic | VICCSAR1169 08/03/2012 | A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma |
| Therapeutic | COGADVL1121 06/13/2012 | ADVL1121 - A Phase II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (IND# 69896) in Children and Young Adults With Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, and Papillary Thyroid Carcinoma |
| Therapeutic | VICCMD1188 06/08/2012 | An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers |
| Correlative | VICCSAR1275 03/21/2013 | Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma |
| Screen, Detect, Diagnose | VICCMD1286 12/17/2012 | Screening Protocol to Detect BRAF V600 Mutation Positive Patients for Enrollment into Clinical Research Studies of Vemurafenib |
| Supportive-Non-Therapeutic | VICCSUPP1170 01/16/2012 | Effect of Manual Lymphatic Drainage on Dysphagia in Head and Neck Cancer Patients Status post Radiation Therapy without or without Concurrent Chemotherapy |
You do not have JavaScript enabled. This site works better with JavaScript turned on.
